Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-12-185902
Filing Date
2012-04-26
Accepted
2012-04-26 16:05:31
Documents
4
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT NO. 1 d340891d10ka.htm 10-K/A 296835
2 SECTION 302 CEO CERTIFICATION d340891dex311.htm EX-31.1 6399
3 SECTION 302 CFO CERTIFICATION d340891dex312.htm EX-31.2 6202
4 SECTION 906 CEO AND CFO CERTIFICATION d340891dex321.htm EX-32.1 4273
  Complete submission text file 0001193125-12-185902.txt   314710
Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01802
Business Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01802 781-238-6621
CORONADO BIOSCIENCES INC (Filer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35366 | Film No.: 12783561
SIC: 2834 Pharmaceutical Preparations